ScholarIQanswers from OpenAlex

Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells

PaperCitations, authors & open-access status

Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells have?

ScholarIQcitation count

Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells has 63 citations in the OpenAlex counts ScholarIQ stores.

When was Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells published?

ScholarIQyear

Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells has 2006 year in the ScholarIQ index.

What is the open-access status of Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells?

ScholarIQoa status

Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells has closed oa status in the ScholarIQ index.

What is the DOI of Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells?

ScholarIQdoi

The DOI for Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells is on the source record.

What is the PMID of Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells?

ScholarIQpmid

The PMID for Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells is on the source record.

What is the OpenAlex record for Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells?

ScholarIQopenalex

The OpenAlex for Rapamycin Inhibits Proliferation of Estrogen-Receptor-Positive Breast Cancer Cells is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial